Table 2.
Health and Economic Outcomes
| Time Horizon | Base Case |
||
|---|---|---|---|
| SGA | CBT | CBT vs. SGA (95% CI) | |
| 1 y | |||
| Costs, $ | |||
| Health care sector | 8100 | 9000 | 900 (500 to 1400) |
| Societal | 14 600 | 16 100 | 1500 (500 to 2500) |
| Quality-adjusted survival, QALYs | 0.708 | 0.715 | 0.008 (−0.013 to 0.025) |
| ICER, $/QALY | |||
| Health care sector | – | – | 119 000 |
| Societal | – | – | 186 000 |
| NMB, $ | |||
| Health care sector | – | – | −200 (−2400 to 1600) |
| Societal | – | – | −700 (−3400 to 1600) |
| 5 y | |||
| Costs, $ | |||
| Health care sector | 57 200 | 55 400 | −1800 (−6800 to 3800) |
| Societal | 90 100 | 87 600 | −2500 (−10 400 to 6200) |
| Quality-adjusted survival, QALYs | 3.238 | 3.293 | 0.055 (−0.044 to 0.160) |
| ICER, $/QALY | |||
| Health care sector | – | – | Cost saving |
| Societal | – | – | Cost saving |
| NMB, $ | |||
| Health care sector | – | – | 7300 (−8100 to 21 700) |
| Societal | – | – | 8000 (−10 400 to 25 300) |
CBT = cognitive behavioral therapy; ICER = incremental cost-effectiveness ratio; NMB = net monetary benefit; QALY = quality-adjusted life-year; SGA = second-generation antidepressant.